Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-24-006958
Filing Date
2024-09-11
Accepted
2024-09-11 16:18:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4886
  Complete submission text file 0001950047-24-006958.txt   6589
Mailing Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121
Business Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121 858-401-7900
Avidity Biosciences, Inc. (Subject) CIK: 0001599901 (see all company filings)

EIN.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39321 | Film No.: 241292861
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AVIDITY BIOSCIENCES, INC. 10975 N. TORREY PINES RD., SUITE 150 LA JOLLA CA 92037
Business Address
Flanagan W. Michael (Reporting) CIK: 0001841990 (see all company filings)

Type: 144